tiprankstipranks
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market
Holding HOWL?
Track your performance easily

Werewolf Therapeutics (HOWL) Financial Statements

616 Followers

Werewolf Therapeutics Financial Overview

Werewolf Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.495; its P/E ratio is -1.10; Werewolf Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue---$ 5.90M$ 8.08M
Gross Profit----$ 8.08M
EBIT$ -15.43M$ -16.45M$ -15.19M$ -9.25M$ -5.10M
EBITDA$ -14.81M$ -15.83M$ -14.73M$ -8.81M$ -4.33M
Net Income Common Stockholders$ -16.67M$ -16.11M$ -16.19M$ -8.29M$ -4.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 122.80M$ 135.30M$ 139.20M$ 130.06M$ 137.45M
Total Assets$ 140.04M$ 153.70M$ 177.60M$ 176.39M$ 185.24M
Total Debt$ 36.78M$ 36.68M$ 51.27M$ 52.19M$ 52.82M
Net Debt$ -86.02M$ -98.62M$ -87.93M$ -77.87M$ -84.64M
Total Liabilities$ 50.66M$ 49.69M$ 60.01M$ 63.94M$ 66.64M
Stockholders Equity$ 89.38M$ 104.02M$ 117.59M$ 112.44M$ 118.60M
Cash Flow-
Free Cash Flow$ -12.46M$ -14.19M$ -15.41M$ -7.43M$ -11.10M
Operating Cash Flow$ -12.46M$ -14.18M$ -15.30M$ -7.21M$ -10.92M
Investing Cash Flow$ -3.00K$ -17.00K$ -111.00K$ -221.00K$ -182.00K
Financing Cash Flow$ -6.00K$ -9.72M$ 20.26M$ 41.00K$ 692.00K
Currency in USD

Werewolf Therapeutics Earnings and Revenue History

Werewolf Therapeutics Debt to Assets

Werewolf Therapeutics Cash Flow

Werewolf Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis